Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 159

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Prognostic factors in 264 adults with invasive Scedosporium spp. and Lomentospora prolificans infection reported in the literature and FungiScope®

Open access
Seidel, Danila, Meißner, Arne, Lackner, Michaela, Piepenbrock, Ellen, Salmanton-García, Jon, Stecher, Melanie, Mellinghoff, Sibylle, Hamprecht, Axel, Durán Graeff, Luisa, Köhler, Philipp, Cheng, Matthew P., Denis, Julie, Chedotal, Isabelle, Chander, Jagdish, Pakstis, Diana Lynn, Los-Arcos, Ibai, Slavin, Monica, Montagna, Maria Teresa, Caggiano, Giuseppina, Mares, Mihai, Trauth, Janina, Aurbach, Ute, Vehreschild, Maria J. G. T., Vehreschild, Jörg Janne, Duarte, Rafael F., Herbrecht, Raoul, Wisplinghoff, Hilmar, Cornely, Oliver A. · 2019 · Critical Reviews in Microbiology

Abstract

Invasive Scedosporium spp.and Lomentospora prolificans infections are an emerging threat in immunocompromised and occasionally in healthy hosts.Scedosporium spp. is intrinsically resistant to most, L. prolificans to all the antifungal drugs currently approved, raising concerns about appropriate treatment decisions.High mortality rates of up to 90% underline the need for comprehensive diagnostic workup and even more for new, effective antifungal drugs to improve patient outcome.For a comprehensive analysis, we identified cases of severe Scedosporium spp.and L. prolificans infections from the literature diagnosed in 2000 or later and the FungiScope V R registry.For 208 Scedosporium spp.infections solid organ transplantation (n ¼ 58, 27.9%) and for 56 L. prolificans infection underlying malignancy (n ¼ 28, 50.0%) were the most prevalent risk factors.L. prolificans infections frequently presented as fungemia (n ¼ 26, 46.4% versus n ¼ 12, 5.8% for Scedosporium spp.).Malignancy, fungemia, CNS and lung involvement predicted worse outcome for scedosporiosis and lomentosporiosis.Patients treated with voriconazole had a better overall outcome in both groups compared to treatment with amphotericin B formulations.This review discusses the epidemiology, prognostic factors, pathogen susceptibility to approved and investigational antifungals, and treatment strategies of severe infections caused by Scedosporium spp.and L. prolificans.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/1040841x.2018.1514366

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 159

Metadata

Authors
Seidel, D., Meißner, A., Lackner, M., Piepenbrock, E., Salmanton-García, J., Stecher, M., Mellinghoff, S., Hamprecht, A., Durán Graeff, L., Köhler, P., Cheng, M. P., Denis, J., Chedotal, I., Chander, J., Pakstis, D. L., Los-Arcos, I., Slavin, M., Montagna, M. T., Caggiano, G., Mares, M., Trauth, J., Aurbach, U., Vehreschild, M. J. G. T., Vehreschild, J. J., Duarte, R. F., Herbrecht, R., Wisplinghoff, H., & Cornely, O. A.
Venue
Critical Reviews in Microbiology
Published
2019-01-02
Volume
45
Issue
1
Pages
1-21
ISSN
  • 1040-841X (ISSN-L)
  • 1549-7828
OpenAlex
W2910164778
Cited by
159
References
4
FWCI
11.50
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prognostic factors in 264 adults with invasive Scedosporium spp. and Lomentospora prolificans infection reported in the literature and FungiScope®. https://app.cochat.ai/papers/10.1080/1040841x.2018.1514366
The paper
Seidel, D., Meißner, A., Lackner, M., Piepenbrock, E., Salmanton-García, J., Stecher, M., Mellinghoff, S., Hamprecht, A., Durán Graeff, L., Köhler, P., Cheng, M. P., Denis, J., Chedotal, I., Chander, J., Pakstis, D. L., Los-Arcos, I., Slavin, M., Montagna, M. T., Caggiano, G., . . . Cornely, O. A. (2019). Prognostic factors in 264 adults with invasive Scedosporium spp. and Lomentospora prolificans infection reported in the literature and FungiScope®. Critical Reviews in Microbiology. https://doi.org/10.1080/1040841x.2018.1514366

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.